We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
03/12/2012 10:53 | Not posted since May when I top sliced and reduced holding. The news from the US looks to me like a deal is about to be done. In what format I am unsure but for ST Jude to come back to the discussion table must surely mean that this is about to be resolved. With this deal in place and no court case looming the share price should respond healthily. | way2000 | |
03/12/2012 10:29 | I am surprised by the deafening silence from the Co re the 7 day trial delay to allow both parties to discuss a solution.(See Roys previous post)They have always been prompt in providing updates re litigation etc. I can only assume that SJ and Aor must have wanted the time to thrash out a deal in private then present it to market before trial restart.Only guessing but otherwise why no update from Aor.Surely a big positive for long suffering Aor shareholders coming shortly. The clock is ticking! regards SP | spurious | |
03/12/2012 10:29 | strange trades today | papillon88 | |
01/12/2012 13:42 | Hi Marlin You are spot on.They are definitely not discussing the weather ! Next week could be very interesting indeed regards SP | spurious | |
01/12/2012 10:35 | (Just for clarity- I have no position here any more, just an interested onlooker). | marlint111 | |
01/12/2012 10:34 | Sounds like potentially very good news to me. It shows AOR are in talks with St Jude about resolving this. That, to me would imply that St Jude may be looking to acquire either Aortech or the Optim IP/rights (why otherwise would Aortech look to resolve this- as they are 'all in' here). | marlint111 | |
01/12/2012 10:25 | This is potentially very good indeed. | gac141 | |
01/12/2012 10:09 | Is this good, bad or indifferent? | tadders2 | |
30/11/2012 21:15 | Just seen on bloomberg tv that St Jude are buying back $1 billion worth of their own stock. This really does seem like a David versus Goliath situation playing out here with AOR. I am a betting man, so I predict that AOR are either made to honour contractual obligations or are made to play out a waiting game. Either way its St Jude for me , although I do hope for George,Patrick & Roy that St Jude are shafted big time. | cocker | |
30/11/2012 13:55 | I think we have to wait and see what the hearing says. I still think Aortech have a very sound case. | gac141 | |
30/11/2012 12:24 | with the rise this week I was hoping we might have had an announcement that an out of court agreement had been struck. That doesnt look to be the case as the share price slowly declines again | papillon88 | |
28/11/2012 18:36 | Ok now I get it! Could get exciting guys! | 1prophet | |
28/11/2012 16:45 | The key issue is what if AOR lose the court case and effectively are locked into the STJ agreement as it stands. And they have lost their chief technical guy. I gather from the snippets of information on the web that 30th Nov is some sort of deadline in the case ..I think for further submissions. | harrogate | |
28/11/2012 15:59 | I think STJ has been severely hit by this court case and the uncertainty surrounding it. I am still of the belief we have a valuable company worth in excess of £2.00 a share to St Jude or another looking for ground-breaking collection of products including the heart valve. Thank you Roy for the comment earlier.. I question why Pither has anything to do with this company still! It was under his Chairmanship that the suicidal deal with STJ was completed. He deserves not one penny of remuneration. | gac141 | |
28/11/2012 15:30 | I wonder how much the share price of STJ has been effected by the current STJ / AOR dispute. AOR current market cap is £3.5 mil STJ could end this dispute, gain some market credibility and own the rights to the IP outright for somewhere near £10 mil about £2 a share I would imagine. Im sure the BOD would consider accepting a bid around that level, which to STJ seems such a small price to pay. If STJ win the court case they will have won the battle but lost the war CRAZY REALLY | papillon88 | |
28/11/2012 08:17 | Continuance of yesterday's action. It does move up fast. | loverat | |
27/11/2012 21:27 | Marlin Appologies for delay but just in. SJ gambled Aor would run out of money and could be picked up from the admistrators for next to nothing. It seriously misjudged the determination of Aor to fight its corner by raising money and damaging SJ where it matters ,in its share price. SJ is not only fighting Aor but faces possible investigation into its Riata and Durata leads from the regulators SJ appears to have gained a slight advantage in the court case by winning an injunction but it is only a temporary injunction and I feel SJ is by no means guaranteed to win and indeed may have recently further damaged its credibility SJ therefore face a triple whammy 1)continue with a damaging court case which it has every chance of losing 2)face the challenge of regulatory scrutiny of its leads without recourse to the full knowledge and help of the manufacturer of Optim and inability to react to recommendations as effectively 3)Risk losing a company that produces Optim which SJ has stated is vital to its future strategy 4)A share price that has been decimated by the uncertainty and a brand that is becoming tainted Common sense would suggest SJ may have reached a tipping point when assessing risk/reward and now would surely be the right time for a bid SJ would have a far better chance of addressing any lead issues with its American regulator in a strong united approach where Optim interaction in the full product make up is fully understood and reaction to recommendations can be better managed and reacted on The risk of losing Optim to a rival would vanish and the chance of developing Ecsil and Elasteon into other markets woud offer real opportunity to SJ Perhaps most importantly SJ could draw a line under a severely damaged share price remove the uncertainty and show itself as a market visionary developing exciting new products backed by Elasteon and Ecsil Its all guesswork really, but as SJ experience the perfect storm, perhaps now really is the time for action regards SP | spurious | |
27/11/2012 19:15 | Hello fellow funguys, or should that be fungis as we all seem to be in the dark and surrounded by who knows what, but perhaps a ray of sunshine breaking through......or perhaps not, who knows!!! As a bit of light relief, a sketch about an accident prone Mr Pither, a bit far fetched as surely no one is that incompetent? | 25october1969 | |
27/11/2012 19:10 | I have been awaken from my slumber. Why? | 1prophet | |
27/11/2012 18:55 | Nobody knows what is really going on here behind the scenes. Brinkmanship, bluff and having tantrums could be all part of it. This share is quite exciting because there are a numerous number of possibilities here which could deliver value. Risky mind. | loverat | |
27/11/2012 18:25 | Spurious. If they were going to do so, wouldn't they have done it by now? Why start shelling out money on lawyers and court cases if you are planning to buy Aor all along? There is no rush on St Jude's part, as the injunction prevents Aortech from terminating supply of the material. | marlint111 | |
27/11/2012 18:09 | Think there must be something about to happen.Pure common sense would suggest St Jude buys us and waste no time repairing its damaged reputation.I strongly feel it risks far too much prolonging this situation by even a few more days. However it may face competition. I still feel Aor will realise in excess of £4 per share in total when its much admired heart valve is sold perhaps separately to Elasteon/Ecsil I feel and hope the end game may be approaching | spurious | |
27/11/2012 17:31 | This has the hallmark of another rise.. last time it got to 120p | gac141 | |
27/11/2012 16:49 | perhaps at long last we are going to see some action regards SP | spurious |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions